Drug Database
Back to search

Netherlands· NL-4b9211cd4ee9

Aciclovir Hikma 250 mg poeder voor oplossing voor infusie

A aciclovir product containing aciclovir, registered in Netherlands by Hikma Farmaceutica (Portugal), S.A.. The same ATC class is registered in 17 of our 19 countries.

ATC J05AB01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedAciclovir Hikma 250 mg poeder voor op…ATCJ05AB01REGISTER NO.NL-4b9211cd4ee9PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about aciclovirAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Aciclovir is registered in 17 of 19 countries.

Countries holding a registration under ATC J05AB01 (aciclovir), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 10 of them publish a price we can compare per daily dose
Search aciclovir products by name

Aciclovir · ATC J05AB01

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of aciclovir costs, country by country.

Normalised to the WHO defined daily dose (4 g), the median price runs from $4.07 in Italy to $13.83 in Switzerland — a ×3.4 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Aciclovir · price per daily dose (4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$13.83
  • IT Italy$4.07
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
ACICLOVIR
Manufacturer
Hikma Farmaceutica (Portugal), S.A.
Country
Netherlands (NL)
ATC code
J05AB01
ATC class
Aciclovir
Defined daily dose
4 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    128456

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

560 interactions on record for aciclovir.

Graded by severity as the source publishes them — 19 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check aciclovir against other medicinesHow interaction checks work

Aciclovir · interactions on record

560 records

  • 19 severe
  • 27 moderate
  • 7 minor
  • 505 info

Most severe, free to view

  • CidofovirJ05AB12severe
  • TemsirolimusL01EG01severe
  • EverolimusL01EG02severe
  • SirolimusL01EG04severe

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under J05AB01

Aciclovir, as other registers publish it.

All aciclovir products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/df769e6d-22e8-448b-8897-a90a692fb43a
GET /v1/drugs/df769e6d-22e8-448b-8897-a90a692fb43a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder voor oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h128456_smpc.pdf",
  "strength": null,
  "atc_label": "Aciclovir",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg128456",
  "excipients": [
    "NATRIUMHYDROXIDE (E 524)",
    "STIKSTOF (HEAD SPACE) (E 941)"
  ],
  "substances": [
    "ACICLOVIR"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h128456.pdf",
  "authorised_at": "2022/10/24",
  "procedure_number": "PT/H/1192/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "128456",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about aciclovir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console